Education
About Us
Working with TipRanks
Follow Us
Icu Medical (ICUI)
NASDAQ:ICUI
Earnings Data
Report Date
Aug 11, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
1.5Last Year’s EPS
1.56Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -8.50%
|Next Earnings Date:Aug 11, 2025
Earnings Call Sentiment|Neutral
ICU Medical's earnings call reflected both positive and negative aspects. The company demonstrated strong revenue growth and effectively managed debt repayment while forming a promising joint venture. However, significant challenges include the impact of tariffs, regulatory issues, and a cautious outlook on guidance. The sentiment is balanced, with highlights and lowlights having a comparable weight.Company Guidance
During the first quarter 2025 earnings call, ICU Medical provided guidance reflecting a solid performance with revenue reaching $599 million, marking a 10% growth on a constant currency basis. Adjusted EBITDA increased by 26% to $99 million, and adjusted EPS rose to $1.72. The company repaid nearly $250 million in principal year to date, bolstering its financial position. ICU Medical's consumables, IV Systems, and Vital Care segments all reported year-over-year growth, with notable contributions from the consumables business, which grew 10% constant currency. Despite challenges posed by recently implemented tariffs, expected to cost $25 to $30 million in 2025, the company anticipates offsetting a significant portion through favorable currency impacts and cost control measures. The guidance confirmed the company's commitment to maintaining the low end of its adjusted EBITDA and EPS projections, despite these headwinds, while continuing to focus on innovation and strategic initiatives to drive future growth.Strong Revenue Growth
ICU Medical reported Q1 revenue of $599 million, reflecting a total company growth of 10% on a constant currency basis and 8% reported. All three reporting segments experienced good year-over-year growth.
Significant Debt Repayment
The company repaid almost $250 million in principal year to date, aided by excess cash generated in Q1 and the net proceeds from a joint venture.
Consumables Business Growth
The consumables business grew by 10% constant currency and 9% reported, driven by new global customer implementations, price improvements, and rapid growth in niche markets.
Vital Care Segment Growth
The Vital Care segment grew by 11% constant currency and 10% reported, with IV Solutions being the largest component of segment growth.
Joint Venture Formation
ICU Medical announced the formation of a joint venture with Otsuka Pharmaceutical Factory, providing better access to technology and a more complete product offering.
ICUI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ICUI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $142.87 | $138.30 | -3.20% |
Feb 27, 2025 | $149.75 | $146.33 | -2.28% |
Nov 12, 2024 | $178.01 | $174.81 | -1.80% |
Aug 07, 2024 | $121.79 | $151.35 | +24.27% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Icu Medical (ICUI) report earnings?
Icu Medical (ICUI) is schdueled to report earning on Aug 11, 2025, TBA Not Confirmed.
What is Icu Medical (ICUI) earnings time?
Icu Medical (ICUI) earnings time is at Aug 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ICUI EPS forecast?
ICUI EPS forecast for the fiscal quarter 2025 (Q2) is 1.5.